Abterra Biosciences uses technology to map the antibody response, and rapidly identify better therapeutic antibodies.
Business Model:
Revenue: $0
Employees: 1-10
Address: 3030 Bunker Hill St
City: San Diego
State: CA
Zip: 92109
Country: US
Abterra Biosciences provides technologies that use the latest in next-generation sequencing, mass spectrometry, and machine learning methods to comprehensively map the antibody response, and rapidly identify better therapeutic antibodies. Abterra Biosciences assembles an interdisciplinary team of data scientists and biologists to reimagine the development of antibody therapeutics. Alicanto, a novel antibody discovery platform developed by Abterra Biosciences, identifies target-specific antibodies in serum. It identifies high-affinity antibodies without the need for time-consuming and inefficient cell selection, fusions, or cloning.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 9/2020 | Grant | $1.4M | 2/2021 | Grant | $1.6M | 2/2021 | Grant | $244k | 4/2020 | Grant | $217k | 7/2020 | Grant | $1M |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|